BRAF and thyroid gland carcinoma: Even though there is a variety among the obtained RefSeq analysis, one seems to be the most probable reason for the displayed results, that is, the 95% similarity (and 95.24% identity) of pVEC-ASO2 with a transcript variant of the BRAF mRNA (Figure S3B), a proto-oncogene that is often mutated in cancer cells (BRAF mutation in thyroid cancer) [45,46,47,48,49].